Mechanisms and consequences of Jak-STAT signaling in the immune system

被引:951
作者
Villarino, Alejandro V. [1 ]
Kanno, Yuka [1 ]
O'Shea, John J. [1 ]
机构
[1] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
TRANSCRIPTION FACTOR STAT3; IFN-GAMMA; CELL-DEVELOPMENT; DNA-BINDING; PSEUDOKINASE-DOMAIN; GENE-REGULATION; T-CELLS; CHROMATIN IMMUNOPRECIPITATION; MYELOPROLIFERATIVE NEOPLASMS; TYROSINE PHOSPHORYLATION;
D O I
10.1038/ni.3691
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Kinases of the Jak ('Janus kinase') family and transcription factors (TFs) of the STAT ('signal transducer and activator of transcription') family constitute a rapid membrane-to-nucleus signaling module that affects every aspect of the mammalian immune system. Research on this paradigmatic pathway has experienced breakneck growth in the quarter century since its discovery and has yielded a stream of basic and clinical insights that have profoundly influenced modern understanding of human health and disease, exemplified by the bench-to-bedside success of Jak inhibitors ('jakinibs') and pathway-targeting drugs. Here we review recent advances in Jak-STAT biology, focusing on immune cell function, disease etiology and therapeutic intervention, as well as broader principles of gene regulation and signal-dependent TFs.
引用
收藏
页码:374 / 384
页数:11
相关论文
共 200 条
[1]   Defective IL-2-mediated IL-2 receptor α chain expression in Stat3-deficient T lymphocytes [J].
Akaishi, H ;
Takeda, K ;
Kaisho, T ;
Shineha, R ;
Satomi, S ;
Takeda, J ;
Akira, S .
INTERNATIONAL IMMUNOLOGY, 1998, 10 (11) :1747-1751
[2]   interleukin-2: Biology, Design and Application [J].
Arenas-Ramirez, Natalia ;
Woytschak, Janine ;
Boyman, Onur .
TRENDS IN IMMUNOLOGY, 2015, 36 (12) :763-777
[3]  
BANCEREK J, 2008, IMMUNITY, V38, P250, DOI DOI 10.1016/J.IMMUNI.38
[4]   Crystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617F [J].
Bandaranayake, Rajintha M. ;
Ungureanu, Daniela ;
Shan, Yibing ;
Shaw, David E. ;
Silvennoinen, Olli ;
Hubbard, Stevan R. .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2012, 19 (08) :754-759
[5]   IL-1 signaling modulates activation of STAT transcription factors to antagonize retinoic acid signaling and control the TH17 cell-iTreg cell balance [J].
Basu, Rajatava ;
Whitley, Sarah K. ;
Bhaumik, Suniti ;
Zindl, Carlene L. ;
Schoeb, Trenton R. ;
Benveniste, Etty N. ;
Pear, Warren S. ;
Hatton, Robin D. ;
Weaver, Casey T. .
NATURE IMMUNOLOGY, 2015, 16 (03) :286-U252
[6]   Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders [J].
Baxter, EJ ;
Scott, LM ;
Campbell, PJ ;
East, C ;
Fourouclas, N ;
Swanton, S ;
Vassiliou, GS ;
Bench, AJ ;
Boyd, EM ;
Curtin, N ;
Scott, MA ;
Erber, WN ;
Green, AR .
LANCET, 2005, 365 (9464) :1054-1061
[7]   STAT1-cooperative DNA binding distinguishes type 1 from type 2 interferon signaling [J].
Begitt, Andreas ;
Droescher, Mathias ;
Meyer, Thomas ;
Schmid, Christoph D. ;
Baker, Michelle ;
Antunes, Filipa ;
Owen, Markus R. ;
Naumann, Ronald ;
Decker, Thomas ;
Vinkemeier, Uwe .
NATURE IMMUNOLOGY, 2014, 15 (02) :168-176
[8]   SUMO conjugation of STAT1 protects cells from hyperresponsiveness to IFNγ [J].
Begitt, Andreas ;
Droescher, Mathias ;
Knobeloch, Klaus-Peter ;
Vinkemeier, Uwe .
BLOOD, 2011, 118 (04) :1002-1007
[9]   Histone Deacetylases 6 and 9 and Sirtuin-1 Control Foxp3+ Regulatory T Cell Function Through Shared and Isoform-Specific Mechanisms [J].
Beier, Ulf H. ;
Wang, Liqing ;
Han, Rongxiang ;
Akimova, Tatiana ;
Liu, Yujie ;
Hancock, Wayne W. .
SCIENCE SIGNALING, 2012, 5 (229)
[10]  
BELL BD, 2000, NAT IMMUNOL, V14, P1